File Download
Supplementary
Conference Paper: Identifying therapeutic chemical agents for osteoarthritis by high throughput screening
Title | Identifying therapeutic chemical agents for osteoarthritis by high throughput screening |
---|---|
Authors | |
Issue Date | 2009 |
Citation | The 55th Annual Meeting of the Orthopaedic Research Society (ORS 2009), Las Vegas, NV., 22-25 February 2009. How to Cite? |
Abstract | INTRODUCTION: An articular cartilage lesion, notably generated by osteoarthritis (OA), is initiated partly by the loss of proteoglycan content from the extracellular matrix and manifests as pain or disturbed joint function [1]. Strategies that restore the proteoglycan content would be of therapeutic benefit to prevent, delay, or even reverse the progression of the lesion. Numerous clinical and experimental approaches have been widely applied [2-4] to relieve the pain or induce healing of the lesion; however these require surgical intervention. Orally administrated … |
Description | Poster no. 1138 |
Persistent Identifier | http://hdl.handle.net/10722/61554 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tsui, YK | en_HK |
dc.contributor.author | Leung, VY | en_HK |
dc.contributor.author | Kao, RY | en_HK |
dc.contributor.author | Masuda, K | en_HK |
dc.contributor.author | Chan, D | en_HK |
dc.contributor.author | Cheung, KM | en_HK |
dc.date.accessioned | 2010-07-13T03:42:18Z | - |
dc.date.available | 2010-07-13T03:42:18Z | - |
dc.date.issued | 2009 | en_HK |
dc.identifier.citation | The 55th Annual Meeting of the Orthopaedic Research Society (ORS 2009), Las Vegas, NV., 22-25 February 2009. | - |
dc.identifier.uri | http://hdl.handle.net/10722/61554 | - |
dc.description | Poster no. 1138 | en_HK |
dc.description.abstract | INTRODUCTION: An articular cartilage lesion, notably generated by osteoarthritis (OA), is initiated partly by the loss of proteoglycan content from the extracellular matrix and manifests as pain or disturbed joint function [1]. Strategies that restore the proteoglycan content would be of therapeutic benefit to prevent, delay, or even reverse the progression of the lesion. Numerous clinical and experimental approaches have been widely applied [2-4] to relieve the pain or induce healing of the lesion; however these require surgical intervention. Orally administrated … | - |
dc.language | eng | en_HK |
dc.relation.ispartof | Annual Meeting of the Orthopaedic Research Society, ORS 2009 | - |
dc.title | Identifying therapeutic chemical agents for osteoarthritis by high throughput screening | en_HK |
dc.type | Conference_Paper | en_HK |
dc.identifier.email | Leung, VY: vicleung@hku.hk | en_HK |
dc.identifier.email | Kao, RY: rytkao@hkucc.hku.hk | en_HK |
dc.identifier.email | Chan, D: chand@hku.hk | en_HK |
dc.identifier.email | Cheung, KM: cheungmc@hku.hk | en_HK |
dc.identifier.authority | Leung, VY=rp01764 | en_HK |
dc.identifier.authority | Kao, RY=rp00481 | en_HK |
dc.description.nature | postprint | - |
dc.identifier.hkuros | 165908 | en_HK |